Menu
The Medical University of Gdansk (GUMed) is the largest medical university in northern Poland. According to the 2021 higher education ranking of the Perspektywy Education Foundation, the GUMed is the first medical school in the country and ranks among the top ten of the best Polish state universities. For many years the GUMed has been consequently realizing its development strategy in the fields of research & innovation. The main achievement and confirmation of its leading role in research is the objective position of the GUMed’s faculties in independent parametric analysis. The Ministry of Science and Higher Education ranked the GUMed’s Faculties with the highest possible grades (A, A+). In 2019, GUMed was also selected by the Polish Ministry of Science and Higher Education as the only medical world-class research institution in Poland, giving it the status of the Research University. GUMed’s scientists have published over 14.906 papers in international journals amounting to an overall impact factor of 15 281,896 between the years 2016 and 2020. During that period, they have 23 patents approved and applied for another 44. GUMed has extensive experience in the preparation, implementation and management of projects financed from external sources. The University is proactive in terms of European Framework Programs and international collaborations in the fields of oncology, cardiology, basic sciences and many other medical and health-sciences-related disciplines.
The Medical University of Gdansk with its expertise in breast cancer diagnosis, treatment and research is one of the core sites drafting clinical requirements and providing training data. It will also provide feedback on developed tools ensuring that the end users are kept in the loop. MUG leads work package five, starting at M24 till M48. Its major research topics would cover radiomics robustness and fairness, real-world clinical usability, explainability and aspects of the long-term use of radiomics tools in clinical practice. This multicontinental, multicenter clinical evaluation study would allow the assessment of radiomics models’ scalability and potential worldwide use.
Maciej Bobowicz, MD, PhD, works as an assistant professor at the Second Department of Radiology, Medical University of Gdansk. He leads the WP5 work package focusing on the multicentric clinical evaluation of predictive AI tools in the RadioVal project. He is also leading a clinical work package WP2 in the HORIZON 2020 European Commission-funded project ‘EuCanImage – A European Cancer Image Platform Linked to Biological and Health Data for Next-Generation Artificial Intelligence and Precision Medicine in Oncology. His main speciality is surgical oncology and he deals with different types of cancer but focuses mainly on breast and colorectal disease. He is an enthusiast of the responsible use of artificial intelligence in medicine, and cancer imaging in particular. His other fields of interest are artificial intelligence in oncology, radiomics, bioinformatics, process automation in radiology, precision medicine in oncology, and new technologies in cancer diagnostics and treatment.
Professor Edyta Szurowska, MD, PhD is the Head of the Second Department of Radiology at the Medical University of Gdansk and the Head of the Department of Radiology in the University Clinical Centre. Her main interests relate to oncologic imaging and neuroradiology. In the area of oncologic imaging, her particular focus is on lung cancer, head and neck tumours as well as abdominal neoplasms. Professor Szurowska’s principal research concerns brain imaging, lung cancer screening, liver and gastrointestinal cancers diagnosis and staging with CT and MRI techniques. Professor Szurowska is the author of more than 120 papers in both international and national journals, and she has been the invited speaker in more than 200 national and international lectures. Since 2016, Professor Szurowska has been the Vice-Rector for Medical Affairs at the Medical University of Gdansk. She remains a practicing radiologist, carrying out many consultations and holds a very active position within the hospital.
Katarzyna Gwoździewicz, MD, PhD, is a lead breast radiologist in the Breast Cancer Unit of the University Clinical Centre and an assistant professor at the Medical University of Gdansk. Her main field of interest is breast imaging including mammography, ultrasonography and magnetic resonance, focusing on the complementarity of methods in the diagnosis of breast disease. She is an active EUSOBI and ESR member.
Joanna Kufel-Grabowska, MD, PhD, is a clinical oncologist in the Department of Oncology and Radiotherapy at, the Medical University of Gdańsk. Dr Kufel’s research interests include breast cancer therapy, oncofertility, pregnancy after breast cancer therapy, the biology of breast cancer in young women and breast cancer in pregnant women. She is also actively involved in several clinical trials.
Elzbieta Senkus-Konefka, MD, PhD is an associate professor at the Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland. Her main scientific interest in breast cancer is the molecular basis of disease in high-risk patients. She is the Faculty Member for Breast Cancer at the European Society for Medical Oncology (ESMO) and European School of Oncology (ESO). She is also involved in developing international guidelines for early and metastatic breast cancer as the Section Editor of the ESMO Guidelines Committee and serves on the Steering Committees of several international clinical trials. Since 2009 dr Senkus-Konefka is a Specialty Editor for “The Breast” journal and has been actively involved in undergraduate and postgraduate teaching, including courses organized by the European Society for Therapeutic Radiology and Oncology (ESTRO), ESMO and ESO. Since 2013 she is a member of the Steering Committee and in the years 2017-19 served as a Secretary of the EORTC Breast Cancer Group (BCG). She has contributed to over 120 peer-reviewed publications, and eighteen book chapters and was a co-editor of two textbooks. Cumulated impact factor of publications: 507; 4733 citations, h-score 32.
